SEC Form 4 · accession 0001127602-15-014864
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 20, 2015 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2015 | M | 15,322 | $53.42 | A | 594,387 | I | By Trusts |
| Common Stock | Apr 20, 2015 | M | 2,592 | $52.65 | A | 2,832 | D | |
| Common StockF3 | Apr 20, 2015 | S | 400 | $183.5325 | D | 2,432 | D | |
| Common StockF4 | Apr 20, 2015 | S | 808 | $184.5309 | D | 1,624 | D | |
| Common StockF5 | Apr 20, 2015 | S | 1,384 | $185.4403 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | $53.42 | Apr 20, 2015 | M | 15,322 | D | Dec 31, 2012 | Dec 31, 2022 | Common Stock | 15,322 | 91,932 | D |
| Stock Options | $52.65 | Apr 20, 2015 | M | 2,592 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 2,592 | 498,017 | D |
Explanation of responses
- F1Exercise of stock options pursuant to an "exercise and hold" transaction where none of the resulting shares were sold.
- F2This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F3This transaction was executed in multiple trades at prices ranging from $183.10 to $183.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $184.03 to $185.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $185.05 to $185.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.